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Polyol pathway mediates high glucose-induced collagen synthesis in
proximal tubule. The poiyoi pathway in diabetes is activated in tissues
that are not dependent on insulin for glucose uptake. To examine the
role of the polyol pathway in renal extracellular matrix accumulation,
we incubated murine proximal tubule cells in either normal or high
glucose concentration in the presence or absence of the aldose reduc-
tase inhibitor sorbinil. Raising medium glucose from 100 to 450 mg/dl
for 72 hours increased cell sorbitol levels sevenfold. Addition of 0.4mM
sorbinil reduced sorbitol content to virtually undetectable levels as
measured by gas chromatography. Sorbinil (0.1 to 0.2 mM) also reduced
the secretion of collagens types IV and I in the high glucose concen-
tration after 48 to 72 hours but had no appreciable effect in the normal
glucose concentration. Concordantly, 0.1 mrt sorbinil inhibited the high
glucose-induced stimulation of al(IV) and a2(I) mRNA levels without
affecting levels in normal glucose concentration. To study the role of
transcriptional activation of collagen genes, we transfected proximal
tubule cells with a chioramphenicol acetyltransferase (CAT) reporter
gene linked to the promoter and regulatory elements of ol(IV) gene.
CAT activity increased several-fold in the cells grown in the high versus
normal glucose concentration; this transcriptional activation in culture
media containing high glucose concentration was reduced by treatment
of the cells with 0.1 m sorbinil. Thus, high ambient glucose activates
the polyol pathway in proximal tubule cells, and may mediate the high
glucose-induced stimulation of gene expression for collagens types IV
and 1. For type IV collagen, activation of the polyol pathway may also
involve, at least in part, transcriptional activation of cis-acting gene
regulatory elements.
Diabetic nephropathy is characterized by cellular hypertro-
phy in both glomerular and tubular compartments, progressive
accumulation of extracellular matrix components in the glomer-
ular mesangium, and thickening of the glomerular and tubular
basement membranes [1—SI. Albeit less well-recognized, pro-
gressive tubulointerstitial fibrosis is also a typical feature of the
disease, particularly when reduction in the glomerular filtration
rate (GFR) becomes apparent [2, 5]. Although capillary hyper-
tension, an abnormal metabolic environment, and genetic pre-
disposition may all participate in the pathogenesis of diabetic
nephropathy, hyperglycemia per se remains an essential factor
that is necessary for the occurrence of the kidney disease, a
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conclusion also supported by evidence from tissue culture
[6-8].
Recent studies in streptozotocin-induced diabetes mellitus in
the rat have provided convincing evidence that the early phase
of kidney involvement is characterized by increased expression
of collagen type IV in the proximal tubular epithelium [9]. We
have previously used proximal tubule epithelial cells main-
tained in continuous cell culture in order to study the direct
effects of high glucose concentration on growth and collagen
synthesis [10—12]. These cells elaborated increased amounts of
collagen types IV and I under the influence of high ambient
glucose [10, 11]. Concordantly, increased steady-state mRNA
levels for the al chain of type IV collagen and the a2 chain of
type I collagen were also demonstrated. Using nuclear run-off
assays to measure in vitro gene transcription rate [10], and the
chloramphenicol acetyltransferase (CAT) reporter gene assay
[8, 10], collagen gene transcription rates were also enhanced
under the influence of high ambient glucose. Thus, elevated
glucose concentration stimulated collagen gene transcription in
proximal tubule cells, and this effect contributed to increased
collagen synthesis and secretion.
The cellular mechanisms involved in the high glucose-in-
duced transcriptional activation of collagen genes are unclear,
but one such mechanism may involve the increased activity of
the polyol pathway by high ambient glucose levels. Since its
identification, the role of the polyol pathway in the myriad
complications of diabetes mellitus has been the subject of
intense investigation [13, 14]. Aldose reductase, the first and
rate-limiting enzyme in this pathway, catalyzes the NADPH-
dependent reduction of hexose or pentose sugars to their
corresponding sugar alcohols, or polyols [1]. This metabolic
conversion is of great functional significance in tissues which do
not require insulin for glucose uptake: the kidney, lens, retina,
and peripheral nerves. Importantly, these organs are also the
sites of significant diabetic complications.
The role of the poiyol pathway in diabetic nephropathy has
been the focus of increased attention. Goldfarb et al [15] have
shown that sorbinil, an aldose reductase inhibitor, greatly
diminished the elevated GFR in short-term streptozotocin-
induced diabetes in rats, presumably by increasing afferent
arteriolar resistance to normal levels. In a six-month random-
ized trial of 20 type I normo-albuminuric diabetic subjects,
ponalrestat reduced renal hyperfiltration [16]. Ponalrestat also
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reduced glomerular prostaglandin production and urinary albu-
min excretion in diabetic rats without altering GFR [17]. The
long-term effects of polyol pathway inhibition on renal extra-
cellular matrix accumulation have not been uniformly favor-
able. The aldose reductase inhibitor Statil did not reduce the
magnitude of glomerulosclerosis in diabetic rats after seven
months despite normalization of erythrocyte sorbitol levels
with this drug [18]. Neither tolrestat [191 nor ponalrestat [20]
reduced the thickening of the glomerular basement membrane
in six-month old severely diabetic rats. Ponalrestat [21] also had
no effect on whole kidney mRNA encoding the a! chain of type
IV collagen in severely diabetic rats. However, it should be
noted that the mRNA for this chain decreased with age in both
normal and untreated diabetic animals [21]. On the other hand,
Patel and Boot-Handford [22] showed diminished al(IV)
mRNA levels in diabetic animals treated with sorbinil for one
month. A decrease in width of the glomerular basement mem-
brane has been reported in long-term diabetic rats fed sorbinil
[23]. These varying results may relate to the difficulty in
examining the effects of the polyol pathway in whole kidney,
the likelihood that total inhibition of aldose reductase activity
was not achieved, the differences in duration and severity of
diabetes, and the characteristics of various animal models.
To further examine the possible role of the polyol pathway in
collagen biosynthesis in cultured proximal tubule cells, we have
undertaken a series of experiments showing that high glucose
stimulates the activity of the polyol pathway as reflected by
marked intracellular sorbitol accumulation. Both the increased
sorbitol production and the accompanying increased collagen
biosynthesis were abrogated by treatment with sorbinil. Thus
these findings are consistent with the hypothesis that increased
activity of the polyol pathway may be involved in mediating
some of the early distinctive changes of hyperglycemia in the
kidney.
Methods
Cell culture
The mouse cortical tubule (MCT) cell line was prepared from
kidney cortex of normal SJL mice [24]. After tubule microdis-
section by one of us (S.G.), proximal tubule cells in primary
culture were immunoselected using specific antibodies against
the 3M-i glycoprotein, a tubular target antigen for autoimmune
nephritis. Transformation with a non-replicating, non-capsid
forming strain of SV-40 resulted in immortalization of the cell
line. We [10—12, 25, 26] and others have extensively character-
ized this cell line as recently reviewed [27]. In summary, the
characteristics of these cells indicating their proximal tubule
origin include: positive staining for alkaline phosphatase and
cytokeratin; surface projections on electron microscopy consis-
tent with brush border villi; high affinity binding sites for
angiotensin II, parathyroid hormone, insulin, insulin-like
growth factor, and epidermal growth factor; and specific trans-
port systems such as sodium-proton antiport and sodium-
phosphate symport. Whether MCT cells resemble more the
convoluted or the straight segment of the proximal tubule has
not been established.
MCT cells were maintained in a humidified atmosphere of 5%
CO2 at 37°C and were passaged every 72 hours. For the
purposes of these studies the growth media of the cells con-
sisted of Dulbecco's modified Eagle medium (DMEM: GIBCO
Laboratories, Grand Island, New York, USA) containing a
physiologically normal D-glucose concentration of 100 mgldl
(5.5 mM) supplemented with 10% inactivated fetal calf serum,
100 U/mI penicillin, 100 g/ml streptomycin and 2 m addi-
tional L-glutamine.
Growth conditions for poiyoi measurements and collagen
mRNA extraction
For each experiment, 2 X 106 MCT cells were plated into
each of four 75 cm2 flasks, and the cells were maintained in the
growth media for several days until a confluent monolayer was
achieved. The cells were rested for 24 hours in serum-free
DMEM containing 100 mg/dl D-glucose. The media were then
changed to serum-free DMEM containing either 100 or 450
mgldl glucose concentration, without or with 0.1 to 0.4 ifiM
sorbinil, and the cells were harvested after two to three days.
These relatively high concentrations of sorbinil were chosen in
order to achieve effective high levels of the drug for up to 72
hours in culture and to assure maximal inhibition of aldose
reductase. These doses did not affect cell viability as assessed
grossly by phase-contrast microscopy nor was there significant
inhibition of cellular proliferation.
Fructose and sorbitol measurements
Polyols were measured as previously reported [14]. Cell
monolayers were washed three times with phosphate-buffered
saline (PBS), and the cells were then lysed with ice-cold
deionized water. A known amount of alpha-methyl mannose
pyranoside was added to each flask before lysis to be used as an
internal standard for subsequent chromatographic assays. After
lysis, the cells were centrifuged at 4°C for 20 minutes, and the
supernatants were collected and stored at —20°C prior to
chromatographic measurement. Barium zinc filtrates of lysed
cells were prepared by the method of Somogyi [281 and lyoph-
ilized. The trimethylsilyl derivatives were extracted with hex-
ane and injected on packed columns of 3% SE-30 on 80/100
GasChrom Q (Supelco) in a Hewlett-Packard 5890 gas chro-
matograph by using flame ionization detectors and a model 3392
integrator. For each experimental condition duplicate flasks
were maintained in order to determine the number of cells.
Polyol levels per 106 cells were reported.
Radioimmunoassay of collagen secretion
Details of the tissue culture procedure were described else-
where [10]. To measure collagen secretion in the conditioned
media, the cells were grown in 24-well plates in the presence of
25 sg/ml L-ascorbic acid and 25 g/ml f3-aminopropionitrile, a
cross-linking inhibitor. After 48 or 72 hours, supernatants were
removed from each plate, transferred into several U-bottom
polyvinyl chloride 96-microtiter wells (Costar, Cambridge,
Massachusetts, USA), and frozen at —20°C for subsequent
solid-phase radioimmunoassay of soluble collagens. Standard
collagens types IV and I were dispensed into polyvinyl chloride
wells at various concentrations for comparison with superna-
tants from MCT cells. The wells were dried overnight at 4°C,
blocked with 4% bovine serum albumin (BSA), and incubated
with 1:100 dilution of affinity-purified polyclonal rabbit anti-
type IV and anti-type I collagen antibodies (gifts of Dr. Antonio
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Martinez-Hernandez, Thomas Jefferson University, Philadel-
phia, Pennsylvania, USA). Binding of these primary antibodies
was measured using '251-labeled anti-rabbit antibodies (10
cpmlwell) in 4% BSA. Binding of supernatants is compared
with known standards as described previously [10, 24]. Colla-
gen secretion was expressed per 106 cells.
RNA isolation and collagen mRNA measurements
After growth in tissue culture flasks, the cells were washed
with PBS then lysed with 0.5% NP-40 in Tris-EDTA buffer.
Replicates of 0.2 x 106 cell-equivalents of cytoplasmic RNA
were denatured into a solution of 40% formalin in l2x SSC
(SSC is 0.15 M sodium chloride and 0.015 M sodium citrate, pH
7.0) at 65°C for 15 minutes, then centrifuged, and supernatants
spotted onto ZetaBind filters (CUNO Laboratory Products,
Meriden, Connecticut, USA) by use of a Hybridot apparatus
(Bethesda Research Laboratories, Bethesda, Maryland, USA).
The dried blots were then pre-hybridized at 42°C for 16 hours in
fluid containing 0.5 M phosphate buffer (pH 7.2), 150 g/m1 Poly
A, 150 g/ml denatured, sheared salmon sperm DNA, 7% SDS,
1% BSA, and 1 msi EDTA. The blots were then labeled in
hybridization fluid containing 32P-labeled cDNA probes for
collagens al(IV) and a2(I), and for glyceraldehyde-3-phosphate
dehydrogenase (GAPDH) (specific activity, 0.5 to 1.0 x l0
cpm/sg) for 16 hours at 42°C. The cDNA inserts used as probes
were isolated by endonuclease digestion from their respective
plasmids [10, 11], which were: a 0.66kb PstI fragment encoding
murine al(IV) collagen gene from pcIS, a 0.85 kb XhoI fragment
containing the promoter-proximal exon region encoding murine
2(I) collagen from pAZ1002 and a 1.3 kb PstI fragment
encoding rat GAPDH gene from pBR322. The probes were
labeled with 32P-dCTP (>3,000 Ci/mmol) by the random hex-
amer priming technique [10, 11]. The filters were washed twice
for 15 minutes in 3x SCC, 0.5% SDS at 55°C and then
autoradiographed (Kodak XAR-5 film) with intensifying screens
at —70°C for one to three days (GAPDH) or 10 to 20 days
(collagens). After probing with the collagen cDNA, the filters
were washed for one to two hours at 65°C with a solution
containing 5 mM Tris, 0.2 mM EDTA (pH 8.0), and 5% sodium
pyrophosphate to remove signal, and then were also rehybrid-
ized with GAPDH cDNA as an internal standard to control for
the amount of RNA loading. Relative mRNA levels were
quantitated by densitometric scanning (Hoefer Instruments,
San Carlos, California, USA) followed by area integration.
Chioramphenicol acetyltransferase (CAT) reporter gene assay
The transient transfection method and CAT enzyme assay
were essentially as previously described [29]. The plasmids
used were: pAoCAT, containing the promoterless CAT gene;
pSV2CAT, containing the CAT gene linked to the SV-40
promoter and enhancer; and p184 (gift of Dr. P. Killen, Univer-
sity of Michigan), containing the CAT gene linked to a large
genomic region which includes the promoter common to the
al(IV) and a2(IV) genes, and a regulatory segment in the first
intron of the al(IV) gene [10, 30]. Ten micrograms of plasmid
DNA were mixed with 500 d of 124 mvt CaCl2. This solution
was then added dropwise to 500 pJ of 50 mrvi HEPES (pH 7.1),
280 msx NaCl, and 1.5 mr.i Na2HPO4 with precipitation occur-
ring over 30 minutes at 22°C. The DNA-calcium phosphate
precipitate was then applied dropwise to cultured MCT cells
under different culture conditions as described above. The next
day, the cells were passed into several sterile petri dishes and
were allowed to adhere and grow in 100 mg/dl glucose over-
night. This maneuver assured that the transfection efficiency
was equivalent among the different petri dishes before the
experimental manipulation. The media were then changed to
fresh serum-free DMEM containing 100 or 450 mgldl D-glucose,
without or with 0.1 m sorbinil, and after 48 hours the cells
were washed several times with ice-cold PBS. Two ml of a
solution of 40 mrvi Tris. HCI (pH 7.5), 10 mrvi EDTA, and 150
mM NaCl were applied to the monolayer, which was scraped off
the flask, pelleted, and subjected to three cycles of freeze-thaw
lysis. Equal amounts of cytosolic protein were mixed in a
reaction mixture of 180 jsl containing 20 sg of acetyl-Co-A, 1
Ci '4C-chloramphenicol (54 pCilmmol, Amersham, Arlington
Heights, Illinois, USA), and 250 mri Tris. HCI (pH 8.0). The
reaction was run at 37°C for 60 minutes. Acetylated chioram-
phenicol derivatives were extracted in ethyl acetate by thin
layer chromatography (TLC) using 25-mm silica gel plates and
chloroform:methanol (95:5) as carrier. TLC plates were then
autoradiographed and bands were cut out and counted for
radioactivity. CAT activity was expressed as percent '4C chlor-
amphenicol acetylated per hour per unit protein.
Statistics
For each individual experiment, the mean of replicate deter-
minations was calculated. The data were presented as means (±
SE) with N indicating the number of different experiments.
Statistical analysis between two groups was performed by
paired or unpaired t-tests, as appropriate. Differences among
several groups were tested by analysis of variance. P < 0.05
was considered a significant difference.
Results
Polyol measurements
Cells exposed to 100 mg/dl D-glucose contained very low but
detectable sorbitol levels (Fig. lA). However, when cells were
exposed to 450 mgldl D-glucose for 72 hours, there was more
than sevenfold increase in cell sorbitol levels. Importantly, this
increase in cellular sorbitol content which was induced by the
elevated glucose concentration was abolished when the culture
medium contained 0.4 ms sorbinil (Fig. lA). Sorbinil treatment
reduced sorbitol content to barely detectable levels in both
normal and high glucose concentration. In other experiments
(not shown), 0.1 mst sorbinil reduced the high glucose-stimu-
lated sorbitol content by approximately 90%.
In contrast, Figure lb shows that the fructose content,
measured concomitantly with sorbitol, was only moderately
higher in the cells cultured in 450 mgldl D-glucose. Moreover,
there was no significant effect on fructose content when the
cells were grown in 0.4 m sorbinil in either normal or high
glucose concentration.
Collagen secretion
Results after 48 or 72 hours of culture were similar and
therefore were pooled; also, the similar results of sorbinil
treatment at 0.1 or 0.2 mri were pooled (Fig. 2). The secretion
rates for collagens types IV and I in cells grown for 48 to 72
hours in 450 mgldl D-glucose were both significantly stimulated
Fig. 1. Effects of high glucose and sorbinil on cell polyol content in
proximal tubule cells in culture. Cell sorbitol (A) and fructose (B) were
measured in cells cultured for 72 hours in serum-free DMEM containing
either 100 or 450 mgldl glucose, without () or with addition of 0.4mM
sorbinil (U). Data (mean SE) are expressed per 106 cells. *p < 0.001
by ANOVA.
(Fig. 2) as previously reported [10, 11]. High glucose increased
type IV collagen by approximately 80%, and type I collagen by
approximately 50%. When 0.1 to 0.2 mai sorbinil was added to
the media, there were significant reductions in the high-glucose-
induced stimulation of collagen secretion rates to levels which
were comparable to those in 100 mgldl glucose. On the other
hand, collagen secretion rates in cells exposed to 100 mgldl
glucose were not significantly altered by the addition of sorbinil.
As expected, the production of type IV collagen in proximal
tubule epithelial cells was quantitatively much greater than of
type I collagen [10, 11].
Glucose, mg/dl
Fig. 2. Effects of high glucose and sorbinil on collagen secretion in
proximal tubule cells. Cells were cultured for 48 or 72 hours in media
containing 100 or 450 mg/dl glucose, without () or with addition of 0.1
or 0.2 mi sorbinil (U). Radioimmunoassay of collagens (type IV in A,
type I in B) was performed on conditioned supernatants. Data were
pooled (mean SE, N = 11) and expressed per 106 cells. *P < 0.05 by
ANOVA.
Collagen gene expression
Figure 3A demonstrates that the mRNA expression of the al
chain of type IV collagen relative to that of GAPDH mRNA was
more than 70% higher in the cells grown for 48 hours in 450
mgldl D-glucose than in 100 mg/dl D-glucose (N = 3, each in
duplicate). This response to high glucose in this series of studies
was somewhat less robust than in our previous studies [10, 11].
Nevertheless, and as seen in Figure 3A, the glucose-induced
increment in the level of al(IV) mRNA was abrogated when the
cells were grown in the presence of 0.1 mt.s sorbinil; the level
attained was similar to that in cells cultured in 100 mgldl
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D-glucose. Sorbinil did not affect the mRNA levels in normal
glucose concentration.
Figure 3B depicts the results of studies on a2(I) collagen
mRNA determination. Cultures for 48 hours in high glucose
increased a2(I) mRNA levels relative to GAPDH mRNA by
more than twofold, and 0.1 m sorbinil normalized these levels
(N = 3, each in duplicate).
Representative mRNA dot-blot hybridizations from one ex-
periment are shown in Figure 3C.
CAT reporter gene assay
Increased collagen gene transcription may account, at least in
part, for increased mRNA levels at steady state. We have
previously reported that 450 mg/dl D-glucose increased the
transcription rates for collagens types IV and I as determined
by nuclear run-off assay in MCT cells [10]. Using CAT reporter
gene assays, we also demonstrated transcriptional activation by
the high glucose concentration [8, 10]. That this effect of high
glucose may also be mediated by increased activity of the
polyol pathway is supported by the observation of an inhibitory
effect of sorbinil on transcriptional activation (Fig. 4). Produc-
tion of acetylated chloramphenicol was increased by 3.5-fold in
p184-transfected cells grown in 450 mgldl D-glucose compared
with cells grown in 100 mgldl (N = 3). The addition of 0.1 mM
sorbinil to the media containing 450 mgldl D-glucose resulted in
a marked decrease in the production of the acetylated product,
Fig. 3. Effects of high glucose and sorbinil on steady-state collagen
mRNA levels in proximal tubule cells. Cells were cultured for 48
hours in media containing 100 or 450 mg/dl glucose without () or
with addition of 0.1 ms sorbinil (U. Dot-blot RNA hybridization
followed by densitometric scanning of autoradiographs were
performed as described in Methods. The data are from three
experiments each performed in duplicate for nl(IV) collagen (A) and
a2(I) collagen (B). Autoradiographs of representative blots from one
experiment are provided in C. The collagen mRNA level relative to
the corresponding GAPDH mRNA level in control cells (100 mgldl
glucose, no sorbinil added) was assigned a value of unity.
to 1.5-fold the level in 100 mgldl D-glucose. These results
indicate that high glucose concentration leads to transcriptional
activation of the al(IV) gene in proximal tubule cells, likely
through increased activity of the polyol pathway. Production of
large amounts of acetylated chioramphenicol by pSV2-trans-
fected cells in normal glucose concentration is shown in lane 1
as the positive control (Fig. 4). As the negative control,
pAo-transfected cells in normal glucose concentration yielded
virtually no acetylated products (lane 2, Fig. 4). As was
demonstrated previously [10], the high glucose concentration in
the culture medium had no significant effect on the CAT
reporter gene assay of cells transfected with either the positive
(pSV2) or negative (pAo) control plasmids (data not shown).
Discussion
To begin to assess the importance of the polyol pathway in
the tubulointerstitial changes of diabetes mellitus we focused in
this study on the high glucose-induced stimulation of collagen
biosynthesis in cultured proximal tubule cells, and the effects
thereon of the aldose reductase inhibitor sorbinil. We first
showed a sevenfold increase in sorbitol content in cells grown
in high glucose that was totally abrogated by the addition of
sorbinil, indicating marked activation of the polyol pathway in
proximal tubule cells exposed to elevated ambient glucose. We
also noted that increasing the glucose concentration in the
culture medium resulted in significant increases in the rate of
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Fig. 4. Effects of high glucose and sorbinil on
transcriptional activation of type IV collagen
in proximal tubule cells. Details of transient
transfection and CAT enzyme activity are
given in Methods. Cells were cultured for 48
hours in media containing 100 or 450 mg/dl
glucose without or with addition of 0.1 mrs
sorbinil (SN). The autoradiographs are for one
representative experiment showing TLC-
separated acetylated (that is, CAT activity)
and unacetylated '4C-chloramphenicol.
Plasmids used for transfection, indicated at
bottom of lanes, were pSV2, a positive-
control plasmid containing CAT gene linked
to SV-40 promoter and enhancer elements;
pAo, a negative-control plasmid containing
CAT gene without regulatory elements; and
p184, containing the CAT gene linked to a
genomic region that includes the promoter
common to the al(IV) and a2(IV) collagen
genes, and a regulatory segment in the first
intron of the al(IV) gene. Cells transfected
with pSV2 and pAo were grown in 100 mgldl
glucose, and CAT activity for either plasmid
was not affected by the high glucose
concentration (not shown).
secretion of collagen types IV and I, accompanied by elevated
levels of the respective mRNAs encoding al(IV) and a2(1).
Importantly, the increments in collagen secretion and message
levels were prevented by the addition of sorbinil. Furthermore,
using the CAT reporter gene assay in transient transfection
experiments, we showed transcriptional activation of the colla-
gen type IV gene under the influence of high glucose and this
response was also largely prevented by the addition of the
aldose reductase inhibitor. These findings indicate that the
observed stimulation by high glucose of collagen biosynthesis in
proximal tubule cells is likely to be mediated by increased
activity of the polyol pathway.
The sorbinil-induced decrease in cellular sorbitol content in
media with high glucose concentration reflects a markedly
enhanced flux of glucose through the polyol pathway, likely
catalyzed by aldose reductase. Although not directly measured
in these studies, the relatively low basal enzymatic activity of
aldose reductase in proximal tubule cells under control condi-
tions [31] was probably markedly stimulated when the cells
were grown in high glucose concentration. However, it should
be noted that the activity of other enzymes (such as aldehyde
reductase) could also have been stimulated. Aldehyde reduc-
tase, an enzyme normally present in high amounts in proximal
tubule epithelium [32], can also reduce glucose to sorbitol and
its activity can be inhibited by relatively high concentrations of
sorbinil. Nevertheless, and irrespective of the relative contri-
bution of either enzyme system to the observed effects of high
glucose in the proximal tubule, the response to sorbinil in the
cells exposed to high glucose provide evidence for increased
flux of glucose through the polyol pathway. Furthermore, the
absence of any significant effect of sorbinil in cells grown in
media with physiologic concentrations of glucose indicate that
the observed changes in collagen biosynthesis were not due to
a nonspecific effect of sorbinil. Sorbinil also had no inhibitory
effect on the expression of the control GAPDH mRNA. A
surprising finding in our study, which has also been noted
before [33], was that sorbinil did not reduce fructose content, as
would be expected if fructose was synthesized directly from
sorbitol. This may indicate that fructose production could also
be governed by metabolic processes other than the polyol
pathway.
In normal kidneys, most aldose reductase activity resides in
the inner medulla and papilla, where aldose reductase-derived
sorbitol synthesis probably serves an osmoprotective function
to maintain cell volume in a hyperosmolar environment [34—36].
Significant levels of aldose reductase are present in mesangial
cells and epithelial podocytes in the glomerulus, and in the
distal convoluted tubule [31, 37]. The presence of aldose
reductase in the proximal tubule under normal conditions is
unclear. Corder et al [35] noted aldose reductase activity in
proximal convoluted tubules derived from nondiabetic kidney,
but most other studies have not borne this out [31, 32, 37, 38].
However, ample evidence exists for the presence of aldose
reductase in cultured proximal tubular epithelium. Renal corti-
cal epithelial cells [39] and proximal tubule cells [40] accumu-
lated sorbitol upon exposure in culture to high ambient glucose,
and this effect was prevented by aldose reductase inhibition.
Petrash et al [41] also demonstrated that both high glucose and
hypertonic media increased sorbitol accumulation in human
proximal tubule cells. Aldose reductase gene expression was
detected in these cells by Northern analysis using a probe which
did not cross react with aldehyde reductase. Interestingly,
although high ambient glucose increased aldose reductase bio-
activity [41], it did not change the amount of enzyme or its
message level.
Although the glomerulus has been the focus of attention in
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diabetes mellitus, the tubulointerstitium has also been recog-
nized as a target of the disease [2]. In fact, the degree of
interstitial expansion is thought to correlate very well with
function and prognosis in many renal diseases including dia-
betic nephropathy [4, 5, 42—44]. Moreover, diffuse tubular
basement (IBM) thickening is a hallmark of the disease, and
this lesion is more likely to be due to the altered metabolic
milieu than to genetic predisposition, as suggested by a study of
identical twins discordant for diabetes mellitus in which TBM
thickness was greater in the diabetic than the nondiabetic
sibling [45]. Animal studies have corroborated the finding of
increased matrix accumulation in the tubular epithelium of the
diabetic kidney. In situ nucleic acid hybridization studies in
streptozotocin-diabetic rats [9] have localized the increased
collagen al(IV) mRNA levels to proximal tubular epithelium in
the deeper cortical and outer medullary portions of the kidney.
It is also of interest to note that kidney expression of type I
collagen mRNA was modestly, but not significantly, increased
[9]. Desjardins et al [46] using protein A-gold immunocyto-
chemical techniques have also demonstrated increased staining
for tsl(IV), a2(IV) and a3(IV) collagen chains along the TBM in
streptozotocin-diabetic rats.
The mechanism of polyol pathway-mediated increase in
collagen synthesis remains to be elucidated, but several possi-
bilities can be entertained including stimulation of transforming
growth factor-/3 [26], activation of protein kinase C (PKC), or
changes in myo-inositoi metabolism or cellular redox potential
[1, 8]. We have not thus far been able to demonstrate an
inhibitory effect of sorbinil on glucose-induced stimulation of
transforming growth factor-a mRNA in MCT cells (unpublished
observations). On the other hand, high glucose stimulates in
glomeruli the de novo synthesis of the PKC activator diacyl-
glycerol (DAG) [47], which in turn leads to transcriptional
activation of collagen genes [48]. High glucose also leads to
increased cytosolic NADH/NAD and lactate/pyruvate ratios
in glomeruli which can be prevented when the diabetic rats are
fed the aldose reductase inhibitor toirestat [33]. Aldose reduc-
tase utilizes NADPH to reduce glucose to sorbitol which is then
oxidized to fructose by sorbitol dehydrogenase, utilizing NAD
as a hydrogen acceptor. Altered cellular myo-inositol metabo-
lism may be playing a role as well. In a previous study on
cultured proximal tubule cells, we showed that elevating the
myo-inositol concentration in the high-glucose medium in-
creased cellular myo-inositol content, reduced type I and type
IV collagen secretion, and normalized steady state levels of
mRNA for the two collagen types [11]. Elevation of tissue
myo-inositol levels would favor incorporation of DAG into
phosphatidylinositol, thereby lowering DAG levels. Moreover,
agonist-induced increases in DAG are prevented by myo-
inositol supplementation [49—Si]. The polyol pathway may
intriguingly be also linked to non-enzymatic glycation, another
mechanism which may lead to diabetic complications in target
organs [52—55]. The sorbitol pathway produces metabolites
capable of non-enzymatically glycating intracellular protein
constituents, which can be further phosphorylated via novel
pathways that are activated in diabetes mellitus [52—54].
In summary, this study has provided evidence that increased
flux of glucose through the polyol pathway may contribute to
the observed accumulation of collagen in the renal tubuloepi-
thelial compartment. Treatment with an aldose reductase inhib-
itor may ameliorate this fibrogenic process. Our in vitro system
allows us to look directly at the effects of the increased activity
of the polyol pathway on collagen synthesis independent of
hemodynamic or hormonal changes known to occur in diabetes
mellitus. However, additional in vivo studies are necessary to
evaluate the efficacy and therapeutic potential of aldose reduc-
tase inhibitors in diabetic nephropathy.
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